IL6 and neoplasm: In nonsmall cell lung cancer, IL-6 upregulated PD-L1 expression through the JAK/STAT3 signaling pathway in vitro and increased the recruitment of MDSCs, M2 macrophages, and regulatory T cells (Tregs) while decreasing the infiltration of CD8+ T cells in tumor samples [21].